Kadence Bio (formerly Kanna Health)

Kadence Bio (formerly Kanna Health) is a clinical-stage biotech looking to bridge the 'intimacy gap' by developing an on-demand solution for premature ejaculation, for which there is currently no FDA-approved treatment.